Alzheimer's Disease
High-dimensional Many-to-many-to-many Mediation Analysis
Nguyen, Tien Dat, Tran, Trung Khang, Truong, Cong Khanh, Can, Duy-Cat, Nguyen, Binh T., Chén, Oliver Y.
We study high-dimensional mediation analysis in which exposures, mediators, and outcomes are all multivariate, and both exposures and mediators may be high-dimensional. We formalize this as a many (exposures)-to-many (mediators)-to-many (outcomes) (MMM) mediation analysis problem. Methodologically, MMM mediation analysis simultaneously performs variable selection for high-dimensional exposures and mediators, estimates the indirect effect matrix (i.e., the coefficient matrices linking exposure-to-mediator and mediator-to-outcome pathways), and enables prediction of multivariate outcomes. Theoretically, we show that the estimated indirect effect matrices are consistent and element-wise asymptotically normal, and we derive error bounds for the estimators. To evaluate the efficacy of the MMM mediation framework, we first investigate its finite-sample performance, including convergence properties, the behavior of the asymptotic approximations, and robustness to noise, via simulation studies. We then apply MMM mediation analysis to data from the Alzheimer's Disease Neuroimaging Initiative to study how cortical thickness of 202 brain regions may mediate the effects of 688 genome-wide significant single nucleotide polymorphisms (SNPs) (selected from approximately 1.5 million SNPs) on eleven cognitive-behavioral and diagnostic outcomes. The MMM mediation framework identifies biologically interpretable, many-to-many-to-many genetic-neural-cognitive pathways and improves downstream out-of-sample classification and prediction performance. Taken together, our results demonstrate the potential of MMM mediation analysis and highlight the value of statistical methodology for investigating complex, high-dimensional multi-layer pathways in science. The MMM package is available at https://github.com/THELabTop/MMM-Mediation.
- North America > United States (0.14)
- Europe > Switzerland > Vaud > Lausanne (0.04)
- North America > Greenland (0.04)
- (4 more...)
- Law > Alternative Dispute Resolution (1.00)
- Health & Medicine > Therapeutic Area > Neurology > Alzheimer's Disease (1.00)
Regularized Modal Regression with Applications in Cognitive Impairment Prediction
Linear regression models have been successfully used to function estimation and model selection in high-dimensional data analysis. However, most existing methods are built on least squares with the mean square error (MSE) criterion, which are sensitive to outliers and their performance may be degraded for heavy-tailed noise. In this paper, we go beyond this criterion by investigating the regularized modal regression from a statistical learning viewpoint. A new regularized modal regression model is proposed for estimation and variable selection, which is robust to outliers, heavy-tailed noise, and skewed noise. On the theoretical side, we establish the approximation estimate for learning the conditional mode function, the sparsity analysis for variable selection, and the robustness characterization. On the application side, we applied our model to successfully improve the cognitive impairment prediction using the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort data.
Probabilistic Joint and Individual Variation Explained (ProJIVE) for Data Integration
Murden, Raphiel J., Tian, Ganzhong, Qiu, Deqiang, Risk, Benajmin B.
Collecting multiple types of data on the same set of subjects is common in modern scientific applications including, genomics, metabolomics, and neuroimaging. Joint and Individual Variance Explained (JIVE) seeks a low-rank approximation of the joint variation between two or more sets of features captured on common subjects and isolates this variation from that unique to eachset of features. We develop an expectation-maximization (EM) algorithm to estimate a probabilistic model for the JIVE framework. The model extends probabilistic principal components analysis to multiple data sets. Our maximum likelihood approach simultaneously estimates joint and individual components, which can lead to greater accuracy compared to other methods. We apply ProJIVE to measures of brain morphometry and cognition in Alzheimer's disease. ProJIVE learns biologically meaningful courses of variation, and the joint morphometry and cognition subject scores are strongly related to more expensive existing biomarkers. Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. Code to reproduce the analysis is available on our GitHub page.
- North America > United States > Georgia > Fulton County > Atlanta (0.04)
- North America > Canada > Quebec > Montreal (0.04)
- Health & Medicine > Therapeutic Area > Neurology > Alzheimer's Disease (1.00)
- Health & Medicine > Diagnostic Medicine > Imaging (1.00)
- Information Technology > Artificial Intelligence > Machine Learning > Statistical Learning (1.00)
- Information Technology > Artificial Intelligence > Representation & Reasoning > Uncertainty > Bayesian Inference (0.34)
- Information Technology > Artificial Intelligence > Machine Learning > Learning Graphical Models > Directed Networks > Bayesian Learning (0.34)
- North America > United States > Illinois (0.05)
- Europe > France (0.04)
- Asia > Middle East > Republic of Türkiye > Karaman Province > Karaman (0.04)
- Asia > Middle East > Jordan (0.04)
- Health & Medicine > Diagnostic Medicine > Imaging (1.00)
- Health & Medicine > Health Care Technology (0.91)
- Health & Medicine > Therapeutic Area > Neurology > Alzheimer's Disease (0.31)
- North America > United States > North Carolina > Mecklenburg County > Charlotte (0.04)
- Asia > Myanmar > Tanintharyi Region > Dawei (0.04)
- Health & Medicine > Diagnostic Medicine (1.00)
- Health & Medicine > Therapeutic Area > Cardiology/Vascular Diseases (0.93)
- Health & Medicine > Therapeutic Area > Neurology > Alzheimer's Disease (0.46)
- North America > United States > North Carolina > Orange County > Chapel Hill (0.04)
- South America > Chile > Santiago Metropolitan Region > Santiago Province > Santiago (0.04)
- Europe > United Kingdom (0.04)
- Asia > China > Chongqing Province > Chongqing (0.04)
- Research Report > Experimental Study (1.00)
- Research Report > New Finding (0.93)
- Health & Medicine > Health Care Technology (1.00)
- Health & Medicine > Therapeutic Area > Neurology > Alzheimer's Disease (0.46)
- North America > United States > California (0.14)
- North America > United States > Texas (0.04)
- North America > United States > Pennsylvania > Philadelphia County > Philadelphia (0.04)
- (2 more...)
- Research Report > New Finding (1.00)
- Research Report > Experimental Study (1.00)
- Health & Medicine > Health Care Technology (1.00)
- Health & Medicine > Diagnostic Medicine > Imaging (0.94)
- Health & Medicine > Therapeutic Area > Neurology > Alzheimer's Disease (0.48)
- Government > Regional Government > North America Government > United States Government (0.46)
- Information Technology > Artificial Intelligence > Representation & Reasoning (1.00)
- Information Technology > Artificial Intelligence > Machine Learning > Statistical Learning (1.00)
- Information Technology > Artificial Intelligence > Machine Learning > Neural Networks > Deep Learning (0.94)
- (2 more...)
- Research Report > Experimental Study (1.00)
- Research Report > New Finding (0.93)
- Health & Medicine > Diagnostic Medicine (0.93)
- Health & Medicine > Therapeutic Area > Neurology > Alzheimer's Disease (0.71)
- Information Technology > Data Science (1.00)
- Information Technology > Artificial Intelligence > Representation & Reasoning > Uncertainty > Bayesian Inference (0.93)
- Information Technology > Artificial Intelligence > Machine Learning > Learning Graphical Models > Directed Networks > Bayesian Learning (0.93)
- (3 more...)
- Europe > United Kingdom > England > Cambridgeshire > Cambridge (0.04)
- Europe > United Kingdom > England > Greater London > London (0.04)
- Asia > China (0.04)